Dianthus Therapeutics
DNTH
DNTH
72 hedge funds and large institutions have $174M invested in Dianthus Therapeutics in 2020 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 25 increasing their positions, 19 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
3% less funds holding
Funds holding: 74 → 72 (-2)
18% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 11
60% less capital invested
Capital invested by funds: $437M → $174M (-$263M)
Holders
72
Holding in Top 10
2
Calls
$1K
Puts
$1K
Top Buyers
| 1 | +$1.58M | |
| 2 | +$1.07M | |
| 3 | +$692K | |
| 4 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$332K |
| 5 |
Truist Financial
Charlotte,
North Carolina
|
+$296K |
Top Sellers
| 1 | -$10.1M | |
| 2 | -$798K | |
| 3 | -$459K | |
| 4 |
MA
MYDA Advisors
Woodmere,
New York
|
-$334K |
| 5 |
VFA
Values First Advisors
Gray,
Tennessee
|
-$331K |